SMH
ONCS

Sanders Morris Harris’s OncoSec Medical Incorporated ONCS Stock Holding History

Sanders Morris Harris’s Portfolio ONCS Stock Details ONCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-114
Closed -$24K – 148
2017
Q3 		$24K Hold
114
– – 0.01% 138
2017
Q2 		$30K Hold
114
– – 0.01% 131
2017
Q1 		$32K Buy
114
+46
+68% +$13.4K 0.01% 142
2016
Q4 		$18K Buy
+68
New +$23.3K 0.01% 125

Other funds holding ONCS

Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CLCM
Crawford Lake Capital Management Lakewood, New Jersey $87.4M AUM 30.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Zurich Cantonal Bank
Zurich Cantonal Bank Zurich, Switzerland $46B AUM 27.59% 1-Year Est. Return
MA
MYDA Advisors Woodmere, New York $608M AUM 77.08% 1-Year Est. Return

Sanders Morris Harris's ONCS Position: Q4 2017 in Review

Sanders Morris Harris sold out of OncoSec Medical Incorporated (ONCS) in Q4 2017, closing a stake of 114 shares — an estimated $24K sold.

Sanders Morris Harris first reported a position in ONCS in Q4 2016 and held it in 4 quarters. The position peaked at $32K in Q1 2017. 34 funds tracked by Wall St. Rank hold ONCS as of Q4 2017.

  • Sanders Morris Harris reported no remaining OncoSec Medical Incorporated position as of Q4 2017 after selling out during the quarter.
  • Sanders Morris Harris sold 114 OncoSec Medical Incorporated shares in Q4 2017, an estimated $24K.
  • Sanders Morris Harris first reported a position in OncoSec Medical Incorporated in Q4 2016 and held it in 4 quarters.
  • Sanders Morris Harris's OncoSec Medical Incorporated position peaked at $32K in Q1 2017.
  • 34 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q4 2017.

Based on Sanders Morris Harris's 13F filing for Q4 2017, filed 15 Feb 2018.